VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,468,000 | +51.0% | 62,800 | 0.0% | 0.01% | +42.9% |
| Q1 2018 | $972,000 | -21.0% | 62,800 | -27.8% | 0.01% | -30.0% |
| Q4 2017 | $1,231,000 | 0.0% | 87,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $1,231,000 | -18.3% | 87,000 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $1,506,000 | +2021.1% | 87,000 | +2383.6% | 0.01% | +1100.0% |
| Q2 2016 | $71,000 | +57.8% | 3,503 | +110.4% | 0.00% | 0.0% |
| Q1 2016 | $45,000 | -99.0% | 1,665 | -96.2% | 0.00% | -98.1% |
| Q4 2015 | $4,519,000 | -44.4% | 44,188 | -3.1% | 0.05% | -47.5% |
| Q3 2015 | $8,129,000 | +1.5% | 45,584 | +26.5% | 0.10% | +4.2% |
| Q2 2015 | $8,012,000 | +8.9% | 36,028 | -2.5% | 0.10% | +3.3% |
| Q1 2015 | $7,354,000 | +37.6% | 36,970 | -1.1% | 0.09% | +37.3% |
| Q4 2014 | $5,345,000 | +24.7% | 37,373 | +14.3% | 0.07% | +15.5% |
| Q3 2014 | $4,286,000 | +16.8% | 32,711 | +12.5% | 0.06% | +5.5% |
| Q2 2014 | $3,668,000 | -8.3% | 29,082 | -4.1% | 0.06% | -14.1% |
| Q1 2014 | $4,001,000 | +4.8% | 30,320 | -6.7% | 0.06% | +1.6% |
| Q4 2013 | $3,816,000 | -22.8% | 32,487 | -31.4% | 0.06% | -27.6% |
| Q3 2013 | $4,940,000 | – | 47,348 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |